SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-24-022939
Filing Date
2024-07-17
Accepted
2024-07-17 17:54:06
Documents
1
Period of Report
2024-07-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 2802
  Complete submission text file 0001437749-24-022939.txt   4447
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Issuer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KEMPHARM, INC. 1170 CELEBRATION BLVD., #103 CELEBRATION FL 34747
Business Address
Clifton R. LaDuane (Reporting) CIK: 0001488774 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36913 | Film No.: 241123203